MENU
INVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Innoviva (INVA) Ownership - Who owns Innoviva?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.15B
P/E Ratio
22.96
Total Cash
260.63M
Projected Growth
N/A
Total Debt
450.91M
Revenue
352.75M
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
4.16
Total Debt/Equity
N/A
Revenue/Share
5.15 USD as % of share price
Fundamentals
INVA
Capitalization
1.15B
P/E Ratio
22.96
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
261M
Total Cash/Share
4.16
Total Debt
451M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.15%
Revenue
353M
ROE
N/A
Book Value
669M
P/B Ratio
1.72
Cash Flow
N/A
Earnings
1.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
626K
Current Ratio
1.79
Current Revenue Per Employee
799178.56
Dividends Per Share - Security
0.00
EBITDA
123M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.84
Revenue To Assets
5.34
Shares Held By Institutions
1.84B
Shares Outstanding - Current
62.6M
Total Liabilities
563M
Total Volume MTD
N/A
Value
N/A
Gain YTD
14.526
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com